IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B 1 and B2 receptors through a STAT6-dependent mechanism


Autoria(s): Souza, P. P. C.; Brechter, A. B.; Reis, R. I.; Costa, C. A. S.; Lundberg, P.; Lerner, U. H.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

06/05/2013

Resumo

Background and Purpose Bone resorption induced by interleukin-1β (IL-1β) and tumour necrosis factor (TNF-α) is synergistically potentiated by kinins, partially due to enhanced kinin receptor expression. Inflammation-induced bone resorption can be impaired by IL-4 and IL-13. The aim was to investigate if expression of B1 and B2 kinin receptors can be affected by IL-4 and IL-13. Experimental Approach We examined effects in a human osteoblastic cell line (MG-63), primary human gingival fibroblasts and mouse bones by IL-4 and IL-13 on mRNA and protein expression of the B1 and B2 kinin receptors. We also examined the role of STAT6 by RNA interference and using Stat6-/- mice. Key Results IL-4 and IL-13 decreased the mRNA expression of B1 and B2 kinin receptors induced by either IL-1β or TNF-α in MG-63 cells, intact mouse calvarial bones or primary human gingival fibroblasts. The burst of intracellular calcium induced by either bradykinin (B2 agonist) or des-Arg10-Lys-bradykinin (B1 agonist) in gingival fibroblasts pretreated with IL-1β was impaired by IL-4. Similarly, the increased binding of B1 and B2 ligands induced by IL-1β was decreased by IL-4. In calvarial bones from Stat6-deficient mice, and in fibroblasts in which STAT6 was knocked down by siRNA, the effect of IL-4 was decreased. Conclusions and Implications These data show, for the first time, that IL-4 and IL-13 decrease kinin receptors in a STAT6-dependent mechanism, which can be one important mechanism by which these cytokines exert their anti-inflammatory effects and impair bone resorption. © 2013 The Authors. British Journal of Pharmacology © 2013 The British Pharmacological Society.

Formato

400-412

Identificador

http://dx.doi.org/10.1111/bph.12116

British Journal of Pharmacology, v. 169, n. 2, p. 400-412, 2013.

0007-1188

1476-5381

http://hdl.handle.net/11449/75352

10.1111/bph.12116

WOS:000318234600013

2-s2.0-84876901330

Idioma(s)

eng

Relação

British Journal of Pharmacology

Direitos

closedAccess

Palavras-Chave #interleukin-1β #interleukin-13 #interleukin-4 #kinin receptors #STAT6 #tumour necrosis factor-α #arginine #bradykinin B1 receptor #bradykinin B2 receptor #bradykinin B2 receptor agonist #bradykinin derivative #calcium #interleukin 13 #interleukin 1beta #interleukin 4 #lysine #messenger RNA #small interfering RNA #STAT6 protein #tumor necrosis factor alpha #animal cell #animal experiment #animal model #calcium cell level #calvaria #cell strain #cell strain mg 63 #controlled study #fibroblast #gene expression #gingiva #human #human cell #ligand binding #mouse #nonhuman #osteoblast #priority journal #protein expression #protein function #protein protein interaction #receptor binding #RNA interference
Tipo

info:eu-repo/semantics/article